1 | Satralizumab (D11079) | [1] Satralizumab Satralizumab | [1] Satralizumab
Satralizumab
(D11079) 💬
| [1] IL6R IL6R 💬
| [11] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [4] 11 11, 13, 86, 113 💬
|
2 | Satralizumab 120 MG (D11079) | [1] Satralizumab Satralizumab | [1] Satralizumab
Satralizumab
(D11079) 💬
| [1] IL6R IL6R 💬
| [11] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 13 13 💬
|
3 | Satralizumab prefilled syringe (D11079) | [1] Satralizumab Satralizumab | [1] Satralizumab
Satralizumab
(D11079) 💬
| [1] IL6R IL6R 💬
| [11] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 113 113 💬
|